Monday, May 03, 2021 8:59:46 AM
Outstanding Shares
22,261,619
Recent PDSB News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:05:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 01:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 12:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:05:43 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 08:39:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:13:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:45:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 12:05:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:16:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:05:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:33:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 10:10:16 PM
- PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 01/22/2024 09:45:19 PM
- PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/04/2023 09:50:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:02:38 PM
- PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer • GlobeNewswire Inc. • 11/28/2023 12:30:00 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM